Turnhout, Belgium

Benedikt Sas

This inventor holds 2 USPTO granted patents. Top assignee: Pharma-Mar, S.a.- Pharmar. Active years: 1996-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Benedikt Sas. Retrieved from https://idiyas.com/inventor/benedikt-sas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1996-1997

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Benedikt Sas: Innovator in Antitumoral Compounds

Introduction

Benedikt Sas is a notable inventor based in Turnhout, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antitumoral activity. With a total of 2 patents, his work is recognized for its potential impact on cancer treatment.

Latest Patents

Benedikt Sas's latest patents include innovative methods for synthesizing areno[e]indols. These compounds serve as intermediates in the synthesis of hexahydroareno(e)cyclopropa(c)indol-4-ones, which exhibit antitumoral properties. The preparation method involves several steps, including the reaction of specific aldehydes and the use of photochemical cyclization to produce the desired compounds.

Career Highlights

Benedikt is currently employed at Pharma-Mar, S.A., where he continues to advance his research in pharmaceutical compounds. His work is characterized by a strong focus on the synthesis of complex molecules that can play a crucial role in cancer therapy.

Collaborations

Throughout his career, Benedikt has collaborated with talented individuals such as Koen Alexander and Jose Delamano Garcia. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Benedikt Sas is a prominent figure in the field of pharmaceutical innovation, with a focus on developing compounds that could significantly impact cancer treatment. His contributions through patents and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…